Related Experiment Video
Updated: Feb 4, 2026

High-Efficiency Transduction of Liver Cancer Cells by Recombinant Adeno-Associated Virus Serotype 3 Vectors
Published on: March 22, 2011
Recombinant Viruses for Cancer Therapy.
Daria S Chulpanova1, Valeriya V Solovyeva2, Kristina V Kitaeva3
1Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan 420008, Russia. daryachulpanova@gmail.com.
Recombinant viruses offer promising cancer therapies by stimulating immune responses or directly targeting tumors. Overcoming current challenges is key to maximizing their therapeutic potential in oncology.
Area of Science:
- Oncology
- Virology
- Immunotherapy
Background:
- Recombinant viruses are emerging as potent therapeutic agents for diverse diseases, notably cancers.
- Engineered for broad tropism and transgene expression, they offer versatile applications in gene therapy.
- Tumor cells can evade immune surveillance, necessitating novel therapeutic strategies.
Purpose of the Study:
- To review current advancements in recombinant virus-based cancer therapy.
- To identify challenges hindering the efficacy of these novel treatments.
- To explore future prospects for recombinant virus-based therapeutic development.
Main Methods:
- Review of existing literature on recombinant virus applications in cancer.
- Analysis of strategies for immune stimulation against tumor antigens.
- Examination of oncolytic virus mechanisms for tumor cell lysis.
Main Results:
- Recombinant viruses can be engineered to elicit anti-tumor immune responses.
- Oncolytic viruses demonstrate specific replication in tumor cells, inducing apoptosis.
- Current approaches face significant hurdles impacting therapeutic success.
Conclusions:
- Recombinant viruses hold substantial promise for innovative cancer treatments.
- Addressing existing challenges is crucial for optimizing therapeutic outcomes.
- Further research is needed to fully realize the potential of recombinant virus therapy in oncology.
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Viral Recombination
Recombinant DNA
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Gene Therapy

